Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes
Patent
1997-08-29
2000-01-18
Kishore, Gollamudi S.
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Liposomes
4241841, 4241931, 42419611, 42419711, 4242041, 436829, A61K 9127, A61K 9133
Patent
active
060155760
ABSTRACT:
A method is provided for inducing a systemic immune response to an antigen in a mammal. The method comprises orally administering lyophilized multilamellar liposomes containing the antigen. The liposomes have a size of from 20 nm to 20 microns. The antigen-containing liposomes are absorbed in the Peyer's patches of the gut. Sufficient antigen-containing liposomes are taken up by macrophages in the Peyer's patches to induce a systemic immune response to the antigen.
REFERENCES:
patent: 3993754 (1976-11-01), Rahman et al.
patent: 4117113 (1978-09-01), Allison et al.
patent: 4145410 (1979-03-01), Sears
patent: 4199565 (1980-04-01), Fullerton
patent: 4229360 (1980-10-01), Schneider et al.
patent: 4235871 (1980-11-01), Papahadjopoulos et al.
patent: 4235877 (1980-11-01), Fullerton
patent: 4474773 (1984-10-01), Shinitzky et al.
patent: 4522803 (1985-06-01), Lenk et al.
patent: 4533254 (1985-08-01), Cook et al.
patent: 4588578 (1986-05-01), Fountain et al.
patent: 4708861 (1987-11-01), Popescu
patent: 4749585 (1988-06-01), Greco et al.
patent: 4776991 (1988-10-01), Farmer et al.
patent: 4820732 (1989-04-01), Shell et al.
patent: 4880635 (1989-11-01), Janoff et al.
patent: 4880835 (1989-11-01), Park et al.
patent: 4955878 (1990-09-01), See et al.
patent: 4975282 (1990-12-01), Cullis et al.
patent: 4997926 (1991-03-01), Haertle et al.
patent: 5008050 (1991-04-01), Cullis et al.
patent: 5030453 (1991-07-01), Lenk et al.
patent: 5149529 (1992-09-01), Ho
patent: 5154930 (1992-10-01), Popescu et al.
patent: 5208036 (1993-05-01), Eppstein
patent: 5352448 (1994-10-01), Bowersock
patent: 5382435 (1995-01-01), Geary
patent: 5573779 (1996-11-01), Sato
patent: 5578309 (1996-11-01), Cutler et al.
patent: 5709879 (1998-01-01), Barchfeld
patent: 5762904 (1998-06-01), Okada et al.
patent: 5773027 (1998-06-01), Bergeron et al.
Aramaki, Y. et al., "Stability of liposomes in vitro and their uptake by rat Peyer's patches following oral administration.", Pharm Res 1993 Aug.; 10(8):1228-1231 (Abstract).
Bowersock, T.L. et al., "Induction of pulmonary immunity in cattle by oral administration of ovalbumin in alginate microspheres.", Immunol Lett 1998 Jan.; 60(1):37-43 (Abstract).
Chen, H. et al., "Lectin-bearing polymerized liposomes as potential oral vaccine carriers.", Pharm Res 1996 Sep.;13(9):1378-1383 (Abstract).
Choi, M.J. et al., "pH-sensitive liposomes containing polymerized phosphatidylethanolamine and fatty acid.", J Biochem (Tokyo) 1992 Nov.;112(5):694-699 (Abstract).
Eldridge, J.H. et al., "Biodegradable microspheres as a vaccine delivery system.", Mol Immunol 1991 Mar.;28(3):287-294 (Abstract).
Freeman, F.J. et al., "Permeability studies on liposomes formed from polymerizable diacetylenic phospholipids and their potential applications as drug delivery systems." Biochim Biophys Acta 1987 May 19;924(2):341-351 (Abstract).
Heller, J. et al., "Controlled release of water-soluble macromolecules from bioerodible hydrogels.", Biomaterials 1983 Oct.;4(4):262-266 (Abstract).
O'Connor, C.J. et al., "Bile salt damage of egg phosphatidylcholine liposomes.", Biochim Biophys Acta 1985 Jul. 11;817(1):95-102 (Abstract).
O'Hagan, D.T. et al., "Biodegradable microparticles for oral immunizaton.", Vaccine 1993;11(2):149-154 (Abstract).
O'Hagan, D.T. et al., "Biodegradable Microparticles as Oral Vaccines", Advances in Mucosal Immunology, Ed. by J. Mestecky et al, Plenum Press, New York, 1995, 1463-1467.
Okada, J. et al., "In vitro evaluation of polymerized liposomes as an oral drug delivery system.", Pharm Res 1995 Apr.;12(4):576-582 (Abstract).
Otterlei, M. et al., "Induction of cytokine production from human monocytes stimulated with alginate.", J Immunother 1991 Aug.; 10(4):286-291 (Abstract).
Regen, S.L.; "Polymerized phosphatidylcholine vesicles as drug carriers.", Ann NY Acad Sci 1985; 446;296-307 (Abstract).
Weng, C.N. et al., "Protective effects of an oral microencapsulated Mycoplasma hyopneumoniae vaccine against experimental infection in pigs.", Res Vet Sci 1992 Jul.;53(1):42-46 (Abstract).
Jack Newman, How Breast Milk Protects Newborns, 1995.
Microfluidics Corp., The Dermasome Difference is More Than Skin Deep.
J.A.E. Balazsovits, et al., Analysis of the effect of liposome encapsulation on the vesicant properties, acute and cardiac toxicities, and antitumor efficacy of doxorubicin, 1989.
J.W. Cowens, et al., Initial Clinical (Phase I) Trial of TLC D-99 (Doxorubicin Ecapsulated in Liposomes), 1993.
N.K. Childers, et al., Oral immunization of humans with dehydrated liposomes containing Streptococcus mutans glucosyltransferase iduces salivary immunoglobulin A.sub.2 antibody responses, 1994.
Microfluidics Corp., Laboratory Microfluidizer M-110 Series.
Liposomal malaria vaccine in humans: A safe and potent adjuvant strategy, Fries, et al., 1992.
Efficacy of a Polyvalent Inactivated-virus Vaccine in Protecting Mice from Infection with Clinical Strains of a Group B Coxsackieviruses, See, et al., 1994.
Gregoriadis et al., "The Immunoadjuvant Action of Liposomes: Nature of Immune Response and Influence of Liposomal Characteristics"; Liposomes as Drug Carriers; Chapter 21; John Wiley and Sons, Ltd., 1988.
Charles O. Elson, Maurizio Tomasi, Mark T. Dertzbaugh, Gregory Thaggard, Robert Hunter and Casey Weaver, "Oral-Antigen Delivery by way of a Multiple Emulsion System Enhances Oral Tolerance", No Date, pp. 156-162.
D.H. Jones, B.W. McBridge, C. Thornton, D.T. O'Hagan, A. Robinson and G.H. Farrar, "Orally Administered Microencapsulated Bordetella pertussis Fimbriae Protect Mice from B. pertussis Respiratory Infection", Feb., 1996, pp. 489-494.
Smadar Cohen, Robert Langer, "Novel Liposome-Based Formulations For Prolonged Delivery Of Proteins And Vaccines", 1995, 813-817.
Steven M. Sugarman, Roman Perez-Soler, "Liposomes in the treatment of malignancy: a clinical perspective", Jan. 30, 231-242.
Gregory Gregoriadis, Ph.D., "The Carrier Potential Of Liposomes In Biology And Medicine (First of Two Parts)", Sep. 23, 1976, 704-710.
Carl R. Alving, "Liposomes as carriers of antigens and adjuvants", Feb. 22, 1991, 1-13.
Christine E. Swenson, Mircea C. Popescu, Richard S. Ginsberg, "Preparation And Use Of Liposomes In The Treatment Of Microbial Infections", 1988, S1-S31.
Joep J. Bergers, Timo L.M. ten Hagen, Els W.M. van Etten, Irma A.J.M. Bakker-Woudenberg, "No Title", Pharmacy World & Service vol. 17, No. 1 1995, 1-11.
James Swarbrick, James C. Boylan, "Encyclopedia Of Pharmaceutical Technology vol. 9", No Date, 1-39.
John H. Eldridge, et al., "Controlled Vaccine Release in the Gut-Associated Lymphoid Tissues, Orally Administered Biodegradable Microspheres Target the Peyer's Patches", 1990, vol. 11, Journal of Controlled Release, pp. 205-219.
Darryl M. See, et al., "Successful Immunization of Mice Using Liposomes Containing Inactivated, Prototype Strains of All Six Types of Coxsackievirus Group B. Virus", Vaccine Research, vol. 6, 1997.
Sophie Kerneis, et al., "Conversion by Peyer's Patch Lymphocytes of Human Enterocytes into M Cells that Transport Bacteria", Science, vol. 227, Aug. 15, 1997.
James L. Madara, "The Chameleon Within: Improving Antigen Delivery", Science, vol. 227, Aug. 15, 1997.
Aramaki in Pharm. Res. 10 #8, p. 1228, 1993.
See Darryl M.
See Jackie R.
Bio-Sphere Technology, Inc.
Kishore Gollamudi S.
LandOfFree
Method for inducing a systemic immune response to an antigen does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for inducing a systemic immune response to an antigen, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for inducing a systemic immune response to an antigen will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-561342